The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
Department of Transplantation Research, Novartis Pharma AG, Basel, Switzerland.
H J
HJ
Schuurman
W
W
Schuler
J
J
Ringers
M
M
Jonker
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D000068338:Everolimus; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008252:Macaca fascicularis; D011090:Polyenes / Q000627:therapeutic use*; D020123:Sirolimus / Q000031:analogs & derivatives; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D000068338:Everolimus; D020123:Sirolimus